Raymond James & Associates’s Aptose Biosciences, Inc. APTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-82
| Closed | -$23.7K | – | 3943 |
|
|
2023
Q1 | $23.7K | Buy |
82
+3
| +4% | +$868 | ﹤0.01% | 3733 |
|
|
2022
Q4 | $20.6K | Buy |
79
+51
| +182% | +$13.3K | ﹤0.01% | 3717 |
|
|
2022
Q3 | $7K | Hold |
28
| – | – | ﹤0.01% | 3778 |
|
|
2022
Q2 | $9K | Hold |
28
| – | – | ﹤0.01% | 3830 |
|
|
2022
Q1 | $17K | Sell |
28
-8
| -22% | -$4.86K | ﹤0.01% | 3897 |
|
|
2021
Q4 | $22K | Sell |
36
-9
| -20% | -$5.5K | ﹤0.01% | 3922 |
|
|
2021
Q3 | $44K | Sell |
45
-16
| -26% | -$15.6K | ﹤0.01% | 3853 |
|
|
2021
Q2 | $92K | Hold |
61
| – | – | ﹤0.01% | 3795 |
|
|
2021
Q1 | $165K | Sell |
61
-6
| -9% | -$16.2K | ﹤0.01% | 3619 |
|
|
2020
Q4 | $132K | Hold |
67
| – | – | ﹤0.01% | 3466 |
|
|
2020
Q3 | $180K | Buy |
67
+9
| +16% | +$24.2K | ﹤0.01% | 3226 |
|
|
2020
Q2 | $164K | Sell |
58
-5
| -8% | -$14.1K | ﹤0.01% | 3160 |
|
|
2020
Q1 | $169K | Buy |
63
+10
| +19% | +$26.8K | ﹤0.01% | 3073 |
|
|
2019
Q4 | $136K | Buy |
+53
| New | +$136K | ﹤0.01% | 3395 |
|